EP2255778A1 - Traitement anti-poux avec composés gazeux dans un espace hermétique - Google Patents

Traitement anti-poux avec composés gazeux dans un espace hermétique Download PDF

Info

Publication number
EP2255778A1
EP2255778A1 EP09163262A EP09163262A EP2255778A1 EP 2255778 A1 EP2255778 A1 EP 2255778A1 EP 09163262 A EP09163262 A EP 09163262A EP 09163262 A EP09163262 A EP 09163262A EP 2255778 A1 EP2255778 A1 EP 2255778A1
Authority
EP
European Patent Office
Prior art keywords
container
gas
acid
lice
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09163262A
Other languages
German (de)
English (en)
Inventor
Menachem Ritterband
Yinon Shlomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVOMIC Ltd
Original Assignee
NOVOMIC Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/473,058 external-priority patent/US20090235949A1/en
Application filed by NOVOMIC Ltd filed Critical NOVOMIC Ltd
Publication of EP2255778A1 publication Critical patent/EP2255778A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D19/00—Devices for washing the hair or the scalp; Similar devices for colouring the hair
    • A45D19/16—Surface treatment of hair by steam, oil, or the like

Definitions

  • the present invention relates to the field of medical treatment systems, more particularly, to a system and method for treating an infestation of head lice.
  • Lice Infestation of the human body by lice is an increasingly prevalent social and health problem in many countries, including the USA Lice infest hundreds of millions of people each year. Lice are very small insects, about 2-3mm in length. They deposit eggs either on a hair or fabric fiber and attach them firmly with a cement-like excretion,
  • the life cycle of lice comprises an egg stage, three nymphal stages, and an adult stage, and takes about one month.
  • a female louse lays approximately 100 eggs, which are glued to hairs of the host.
  • the eggs generally hatch in about six to ten days, depending on temperature.
  • the nymphs, (the larval stage in insect development), and adults suck blood, causing disturbance (itching, also known as pruritus) and secondary infection.
  • the empty shells remaining after the nymphs emerge from the eggs look like white grains of sand.
  • Tracheae are a system of internal tubes (invaginations of the cuticle) penetrating the insect's body, through which air diffuses or is being pumped directly to the body tissues. Within body cells, chemical respiration takes place in the mitochondria, where ATP is produced under oxygen consumption.
  • the common treatment methods against lice involve liquids or lotions.
  • a method and device for eradicating lice and nits form an infested area, particularly the scalp of a human being comprises a plastic or rubber cap for covering the head of a human being, and means for filling the cap with an inner gas, such as carbon dioxide from a pressurized-gas cartridge, in order to suffocate the lice and the nits enclosed by the cap, is described in EP Patent Application No. 8663016.9 , publication No. 022100a4 A2, of Scolnik et al. filed October 30, 1986 .
  • a formulation for controlling human lice which discloses pediculicidal formulations comprising a spinosyn, or a physiologically acceptable derivative or salt thereof, and a physiologically acceptable carrier, and methods of controlling lice infestations in a human with these formulations are provided in International Application No PCT/US1999/013925 , Publication No. WO/2000/001347, of Snyder, filed June 21. 1999
  • a pediculicide composition in particular, a composition comprising a sesquiterpene alcohol and a suitable carrier, is described in International Application No. PCT/AU2006/001720 , Publication No. WO/2007/056813 . of Found, filed November 17, 2006.
  • head lice are small hard-shelled ectoparasites which cling to hair shafts while feeding, mating and laying eggs.
  • the louse must remain on the head or it will die within a short period of time. Head lice proliferate at an enormous rate.
  • a louse is ready to mate and reproduce within 10 hours after hatching. Under ideal conditions, a female louse may produce up to 300 eggs in its lifetime. Ideal conditions include an adequate food supply, environmental temperatures from about 28°C to about 32°C, and relative humidity of about 70% to about 90%.
  • the louse's hard chitinous exoskeleton serves as protection from external elements Lice eggs (or ova) are similarly protected by a chitinous sheath surrounding the eggs and attached to the hair shaft.
  • lice may be affected by the use of an insecticide, the eggs often remain resistant to attack.
  • present art optimum treatment of a lice infestation includes both a pediculicide, which kills the adult lice, and an ovicide, which interrupts the development of the eggs
  • Treatment for eliminating head lice traditionally included home remedies such as smearing mayonnaise, olive oil, hair pomade, or some other heavily viscous material about an infested scalp coupled with rigorous combing of the hair and meticulous removal of adult lice, nymphs, and nits. Though these home remedies do not kill head lice, the prevailing thought is that the viscosity of the material makes it hard for head lice to roam about the scalp, making for easy removal Such home remedies are usually ineffective at controlling head lice due to the ability of the lice to revive rapidly once these materials are removed.
  • Over-the-counter insecticides typically have pyrethrins or permethrin as active ingredients
  • Biologically active agents have been used for some time in attempts to control lice.
  • lindane gammabenzene hexachloride
  • organophosphates malathion
  • natural pyrethrins and synthetic compounds known as pyrethroids (such as permethrin) have been used as pediculicides in lice treatment formulations
  • pyrethroids such as permethrin
  • Lindane has a poor safety profile, and lice have developed resistance to it.
  • Natural pyrethrin requires frequent follow-up treatments because it provides only short term residual action.
  • Synthetic pyrethroids although more effective against lice than natural pediculicides, are often more toxic to the subject being treated,
  • None of the prior art provides a sufficiently effective solution, and there is therefore a need for a system and a method for treating an infestation of head lice.
  • the present invention teaches an effective solution for an infestation of head lice, including a system and method of use, which eliminates both the lice and their eggs by means of effective insertion of gas near the roots of the patient's hair, with the gas including toxic material or materials, and enabling a combined attack also including suffocating gases.
  • the system for treating lice and nits on a head of a patient includes a cap for defining an airtight space around the head and a container for storing a mixture of gases and compressed gases for treating lice.
  • a gas release mechanism for delivering, the mixture of gases into the airtight space is also provided.
  • the mixture of gases is selected so that it causes irreversible damage to at least one essential mechanism of said lice.
  • an effective concentrations of acidic vapors in general and Carboxylic acids in particular are applied.
  • the invented treatment is based on the realization that live lice and their eggs are damaged by inhalation or absorption of reactive acidic gas or vapor.
  • the present invention includes compositions comprising of carboxylic acids and methods of their application to human subjects.
  • the method demands prior covering of the head with a covering cap and then after introducing the gas or vapor composition comprising of carboxylic acid into the space under said cap. That introduction is preferably done via dedicated passages incorporated into said cap
  • the process of evaporation in a closed container will proceed until there are as many molecules returning to the liquid as there are escaping. At this point the vapor is said to be saturated, and the pressure of that vapor (usually expressed in mmHg) is called the saturated vapor pressure. At room temperature, the saturated vapor pressure is the maximum partial pressure concentration at which the gas can be obtained in gaseous form.
  • each of said carboxylic acids components in the applied gas or vapor compositions is selected to be on the one hand effective in reducing the survival of lice and/or eggs and on the other hand to be of tolerable irritability to the skin of human subjects.
  • Effective concentrations satisfying the above constrains, in part from room temperature saturated vapor saturation pressure can be selected for example from: between 1% to 5%, between 5% to 10%, between 10% to 20%, between 20% to 30%, between 30% to 40%, between 40% to 50%, between 50% to 60%, between 60% to 70%, between 70% to 80%, and between 80% to 90%.
  • a mixture of more than one type of carboxylic acid is contained in the composition according to the present invention.
  • An advantage of such a mixture is that, since each type of carboxylic acid is active in deactivating lice, and since the maximum gas concentration of each carboxylic acid is limited by its associated saturation partial pressure at room temperature, the use of a mixture of several carboxylic acids can produced an overall increase in the total vapor concentration of effective carboxylic acids active ingredients.
  • One type of gas or gas mixture may target the respiratory system by attacking the soft tissues or by elimination of oxygen from binding to the oxygen carrying protein of the lice.
  • One type of gas or gas mixture may target the respiratory system by attacking the soft tissues (for example vapors of acids such as acetic acid, hydrochloric acid and nitric acid), or by elimination of oxygen from binding to the oxygen carrying protein of the lice (for example carbon monoxide).
  • the soft tissues for example vapors of acids such as acetic acid, hydrochloric acid and nitric acid
  • oxygen carrying protein of the lice for example carbon monoxide
  • gasses targeting other targets such as the reproductive system (e.g. some of the organophospates), or nervous system(e.g., insecticides belonging to organochlorines, carbamates, and organophosphates) may be combined at the same time, before, or after treatment with the first gas mixture
  • the combination of gasses for targeting two or more different systems may improve the effectiveness of treatment.
  • treatment is done first with one type of gas and afterwards with another type of gas, for example, the lice are initially attacked with toxic gas which diminishes their resilience, and afterwards they are attacked with suffocating gas This way, the use of toxic gas can be reduced.
  • the systems of the lice that are attacked include: the respiratory system, by attacking mucous membrane tissue; the respiratory system, by attacking joints; the respiratory system, by disrupting the body's absorption of oxygen; the nervous system; and the reproductive system.
  • the dilution of the carboxylic acid active ingredient in the applied compositions may be in liquids such as water or in other gases such as air or water vapor, but these examples should not be taken as limiting
  • compositions may be in liquid or compressed gas form
  • release and application of said composition onto the proximity of the human head subject is in gas or vapor form.
  • Processes of creating a carboxylic acid gas or vapor from a storage compartment can be achieved in many forms, also including: reaction of high concentration acid with water, and compressed gas containers.
  • a particular benefit of the formulations is their effectiveness on both lice and eggs, and against louse species that have become resistant to currently used products.
  • Another benefit of the present invention is that there is no need for intensive washing of the hair after application of the treatment.
  • Carboxylic acids are known as a general family of chemicals representative members of which are selected from the group comprising of: formic acid (insect stings), acetic acid, propionic acid, butyric acid, valeric acid (valerian), caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, palmitic acid, and stearic acid
  • carboxylic acids most effective for use according to the present invention are formic acid and acetic acid.
  • HCO OH or CH 2 O 2 is the simplest carboxylic acid.
  • Acetic acid, CH 3 COOH, or C 2 H 4 O 2 also known as is an organic acid , is a simple carboxylic acid too, which is a water-soluble component of vinegar , and has been used, in liquid, as a folk remedy which dissolves the cement of lice eggs.
  • a vapor mixture of carboxylic acid in air is first produced in a closed container of volume V con .
  • Said closed containers can be selected from the group af: bottles, bags, balloons, or other containers known in the art.
  • the gas from said container is to be delivered into the space between the head cap and the patient scalp. It is assumed that there is some desired predetermined vapor concentration C v of a selected carboxylic acid, in order to create an effective formulation according to the present invention.
  • the production for such vapors from solid or liquid forms of carboxylic acids can be done in the following production process: (a) A thin film or powder of a carboxylic acid is first enclosed between two strips or plates to create a "strip source" The strip source is placed inside a container, (b) The quantity of carboxylic acid contained in the strip source is selected such that if it is evaporated within said selected container with volume V con then it can create a vapor of said carboxylic acid with at least with the desired concentration C v . (c) The strip source is placed inside the selected container, (d) To create the carboxylic acid vapor at any prescribed or desired time, the two sides of the strip source are separated so as to reveal the included film or power of carboxylic acid to contact with the surrounding air within said container. (e) The container is then kept sealed at least for the amount of time that is required for sufficient evaporation of said carboxylic acid film or powder in the amount to create the desired concentration C v within said container.
  • a system for treating lice and nits on a head of a patient including: a container for storing a predetermined volume mixture of gases for treating lice and nits; a mixture of gases for treating lice stored inside the container; an inlet tube having a first end and a second end, wherein the first end is operatively connected to the container a cap operatively connected to the second end of the inlet tube; and a sealing means, for preventing gas flow from any space between the cap and the head, securely connected to the cap, wherein the mixture of gases comprises at least one gas that causes irreversible damage to at least one essential mechanism of the lice, wherein the amount of the mixture of gases stored in the container, when released outside the cap, is diluted by surrounding air such that the diluted mixture reaches the patient at non-toxic levels; and a gas distribution device operatively connected to the inlet tube, the gas distribution device including: a gas distribution device base, having an interior volume; and a plurality of gas delivery pins
  • the mixture of gases for treating lice and nits stored inside the container has an effective amount of an acidic active ingredient component.
  • the acidic active ingredient component is selected from the group consisting of: carboxylic acid, a derivative, and a salt thereof, associated with a physiologically acceptable carrier.
  • the acidic active ingredient component is selected from the group consisting of: hydrogen chloride, carboxylic acids, a product of a reaction of carboxylic acid with water, and a derivative or salt thereof, associated with a physiologically acceptable carrier.
  • the container is selected from the group consisting of: a container having a predetermined volume between 5cc and 200cc, a predetermined volume between 200cc and 300cc, a container having a predetermined volume between 300cc and 500cc, a container having a predetermined volume between 500cc and 700cc, a container having a predetermined volume between 700cc and 1000cc, a container having a predetermined volume between 1000cc and 1500cc, a container having a predetermined volume between 1500cc and 2000cc, and a container having a predetermined volume between 2000cc and 3000cc,
  • the carboxylic acid is selected from the group including of: formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, palmitic acid, and stearic acid.
  • the mixture of gases comprises at least two different acidic active ingredient substances selected from the group consisting of: carboxylic acids, a product of a reaction of carboxylic acid with water, a derivative or salt thereof, associated with a physiologically acceptable carrier, and hydrogen chloride.
  • the two different acidic active ingredient substances are selected from the group consisting of: acetic acid, formic acid, a product of a reaction of acetic acid with water, and hydrogen chloride.
  • a concentration of one or more of the acidic active ingredient is a component of a compound, has partial pressure conditions, in terms of parts from saturated normal temperature and pressure, wherein the partial pressure has a minimum percentage value and maximum percentage value, and wherein the minimum percentage value and maximum percentage value are selected from the group consisting of: a minimum percentage value of 5% and a maximum percentage value of 10%, a minimum percentage value of 10% and a maximum percentage value of 20%, a minimum percentage value of 20% and a maximum percentage value of 30%, a minimum percentage value of 30% and a maximum percentage value of 40%, a minimum percentage value of 40% and a maximum percentage value of 50%, a minimum percentage value of 60% and a maximum percentage value of 70%, a minimum percentage value of 70% and a maximum percentage valve of 80%, a minimum percentage value of 80% and a maximum percentage value of 90%, and a minimum percentage value of 90% and a maximum percentage value of 100%.
  • the system for treating lice and nits further including: a second container for storing a predetermined volume mixture of gases for treating lice and nits; a second mixture of gases for treating lice stored inside the second container; a second inlet tube having a first end and a second end, wherein the first end is operatively connected to the container, and wherein the second end is operatively connected to the cap.
  • system for treating lice and nits further including: a unidirectional valve operatively connected to the cap.
  • the container is a rigid container.
  • a system for treating lice and nits on a head of a patient including: a gas container for storing a predetermined volume gas, wherein the container is selected from a group consisting of a rigid container and an elastic container; a gas stored inside the gas container; an active material container having a first end and a second end, wherein the first end of the active material container is operatively connected to the gas container; an active material for treating lice and nits stored inside the active material container; an inlet tube having a first end and a second end, wherein the first end of the inlet tube is operatively connected to the second end of the active material container; a cap operatively connected to the second end of the inlet tube; and a sealing means, for preventing gas flow from any space between the cap and the head, securely connected to the cap, wherein the mixture of gases comprises at least one gas that causes irreversible damage to at least one essential mechanism of the lice, wherein the amount of the mixture of gases stored in the container
  • a method for treating lice and nits on a head of a patient including: mounting on a head of the patient a gas distribution device, the gas distribution device includes a plurality of gas delivery pins; mounting a cap over the head of the patient; connecting an inlet tube part of the gas distribution device to an inlet part of a gas container: delivering, by means of the gas distribution device, a predetermined volume of a first gas mixture containing an effective amount of gas mixture for treatment of lice infestation; waiting at least a predetermined minimal duration time; and removing the cap from the head after the predetermined minimal duration time.
  • the method of further including: delivering, by means of the gas distribution device, a predetermined volume of second gas mixture containing effective amounts of gas mixture for treatment of lice infestation.
  • the first gas mixture further comprises at least 50 percent atmospheric air.
  • the first gas mixture further comprises acetic acid as an active ingredient.
  • the present invention is of a system and a method for treating lice and nits on a head of a patient.
  • the term "effective amount of an acidic active ingredient component” and the like refer to quantity and qualities of an active ingredient component sufficient to exterminate lice and nits on a patient's head. These can be determined according to experimental results.
  • the disclosed invention describes a system and method for treating lice on a patient's head.
  • the invention utilizes a cap for defining the space around the treated hair, and an airtight sealing of the space around the treated hair, to apply a gas for treating lice. Reducing the volume that is treated allows using a small amount of gas, such that in case of releasing the gas outside the cap, the patient faces no danger due to the strong dilution of the gas. Keeping the gas compressed in a container enables a rapid delivery of the gas into the airtight space.
  • Additional options for delivery of the gas also include use of a flexible gas container which is pressed manually, a gas container built as a cylinder and piston which is pressed manually, or a container including a pump which can be activated manually or by means of a small engine, which could be electric for example.
  • Figure 1 illustrates a first embodiment of a system 100a, for treating lice and nits, on a head 300 of a patient, according to the present invention.
  • the first embodiment of a system 100a comprises an airtight cap 13 defining an airtight space 16 around head 300, a rigid container 11a for storing a mixture of gases 15a for treating lice and an inlet tube 12a for delivering mixture of gases 15a into airtight space 16 as an aerosol.
  • Cap 13 is kept airtight by a sealing means 17 at the rim of cap 13.
  • Mixture of gases 15a comprises at least one gas that causes irreversible damage to at least one essential mechanism of the lice
  • Rigid container 11a is located outside cap 13, and is coupled to cap 13 by inlet tube 12a, that comprises a tube.
  • cap 13 If a segment of cap 13 is removed, and also if cap 13 is made of translucent material, the patient's hair 14 can be seen, as well as at least a part of airtight space 16, which is the volume between head 300 and hair 14, and the internal side of cap 13 .
  • Airtight space 16 is not fixed, seeing as cap 13 can be made of material which is not rigid and therefore can change shape according to the regimen of pressures and forces applied to it.
  • Rigid container 11a contains a mixture of gases 15a which have a higher pressure than that of the environment, and thanks to the pressure difference, are delivered to the airtight space 16 in free flow, such as flow of fluid through an open tap.
  • An additional option is storage of the mixture of gases 15a at a pressure of one atmosphere and delivering it when desired by means of activation of a pump or any other method which causes it to flow.
  • an elastic container 11b which contains the mixture of gases 15a.
  • the delivery of gas is done by pressure applied to compress the elastic container 11b.
  • the first embodiment of a system 100a can also include a unidirectional valve 18 which enables flow of air and mixture of gases 15a out of the airtight space 16 when the pressure rises above a predefined value, as well as a unidirectional valve 18 assembled to the inlet tube 12a, preventing the return of the mixture of gases 15a from the airtight space 16, to the rigid container 11b or to the elastic container 11b, according to the type of container used.
  • a unidirectional valve 18 which enables flow of air and mixture of gases 15a out of the airtight space 16 when the pressure rises above a predefined value
  • a unidirectional valve 18 assembled to the inlet tube 12a, preventing the return of the mixture of gases 15a from the airtight space 16, to the rigid container 11b or to the elastic container 11b, according to the type of container used.
  • the mixture of gases 15a can includes various concentrations of toxic gases, suffocating gases, or combinations of toxic and suffocating gases.
  • gasses examples include: vapors of acids such as acetic acid, hydrochloric acid and nitric acid, for attacking the respiratory system by attacking the soft tissues; carbon monoxide, for attacking the respiratory system by preventing oxygen from binding to the oxygen carrying protein of the lice; organophospates, for attacking the reproductive system; and insecticides belonging to organochlorines, carbamates, and organophosphates for attacking the nervous system.
  • acids such as acetic acid, hydrochloric acid and nitric acid
  • carbon monoxide for attacking the respiratory system by preventing oxygen from binding to the oxygen carrying protein of the lice
  • organophospates for attacking the reproductive system
  • insecticides belonging to organochlorines, carbamates, and organophosphates for attacking the nervous system.
  • Figure 2 illustrates a second embodiment of a system 100b, for treating lice and nits, on a head 300 of a patient, according to the present invention.
  • the second embodiment of a system 100b comprises of an airtight cap 13 defining an airtight space 16 around head 300, a container which can be a rigid container 11a or an elastic container 11b, for storing a mixture of gases 15a for treating lice and a gas release mechanism 12b for delivering mixture of gases 15a into airtight space 16.
  • Cap 13 is kept airtight by a sealing means 17 at the rim of cap 13.
  • Mixture of gases 15a comprises at least one gas that causes irreversible damage to at least one essential mechanism of said lice.
  • the gas release mechanism 12b is a release valve contained within the containers.
  • the container is attached to the inner side of cap 13.
  • Figure 3 illustrates the first embodiment of a system 100b, for treating lice and nits, on a head 300 of a patient, having two sets of rigid containers 11a, inlet tubes 12a, and unidirectional valves 18, according to the present invention.
  • This configuration enables feeding two types of gasses or of mixtures of gasses into the airtight space 16 at the same time or at different time.
  • a suitable regimen of pressures can be used to press the first gas out of unidirectional valve 18 by means of the second gas
  • This valve is directed to enable only outward flow, while two additional unidirectional valves 18 are directed to prevent flow back into each one of both rigid containers 11a.
  • Either of the rigid containers 11a can be replaced with an elastic container 11b.
  • Figure 4 illustrates the first embodiment of a system 100b, for treating lice and nits, on a head 300 of a patient, having two sets of rigid containers 11a, unidirectional valves 18, and inlet tubes 12a, according to the present invention, while both of the inlet tubes 12a join into a single inlet tube, according to the present invention.
  • This configuration also enables feeding two types of gasses or mixtures of gasses into the airtight space 16 at the same time or at different times.
  • a suitable regimen of pressures can be used to press the first gas out of unidirectional valve 18 by means of the second gas.
  • This valve is directed to enable only outward flow, while two additional unidirectional valves 18 are directed to prevent flow back into each one of both rigid containers 11a. Either of the rigid containers 11a can be replaced with an elastic container 11b.
  • Figure 5 illustrates the third embodiment of a system 100c, for treating lice and nits, on a head 300 of a patient, having a gas distribution device 20, according to the present invention.
  • the gas distribution device 20 serves for delivery and distribution under hair on a human scalp
  • the solution to the first problem is to put a well-sealed cap over the head, and deliver the gas under the cap. Yet, as the gas is delivered from the top above the hair, only a minor fraction of it reaches under the hair in the proximity of the scalp skin (near the hair roots). Hence, such delivery of gas has a deficient effectiveness in treatment of lice infestation.
  • a gas distribution device 20 improve the effectiveness of gas treatments of lice infestations
  • Figure 6a illustrates a bottom view of a gas distribution device 20, according to the present invention, upon which the section plane a-a is marked.
  • the present illustration shows a gas distribution device base 21, to the bottom of which are connected gas delivery pins 22
  • Figure 6b is a cross sectional view a-a schematic illustration of an exemplary, illustrative embodiment of a gas distribution device 20, according to the present invention.
  • the key element of the gas distribution device 20 is a series of gas delivery pins 22 with outlet holes 23 for gas or vapor delivery.
  • gas delivery pins 22 may be short or elongated, stiff or flexible, with one or many outlet holes 23, etc.
  • the gas delivery pins 22 are attached to and distributed over a common gas distribution device base 21.
  • the gas distribution device base 21 has an interior volume 24
  • An inlet tube 12a is connected to the gas distribution device base 21.
  • this "brush" of pins is held in place pressed onto the scalp, such that the outlet holes 23 are under the hair in proximity to the scalp skin Consequently, the gas is distributed as desired under the hair in proximity to the scalp skin.
  • the end of said gas pins is rounded, and the outlet holes 23 are sideways from the shaft of the pins (as illustrated in the present figure).
  • the covering cap 13 is then put over the head and the gas distribution device 20, so as to prevent the delivered gas from escaping the proximity of the head.
  • a gas distribution device 20 in the third embodiment of a system 100c, for treating lice and nits.
  • the inlet tube 12a can go through the cap 13
  • the gas distribution device 20 and the cap 13 are a single unit and are placed together on the patient's head.
  • inlet tube 12a can be a continuous tube connecting the rigid container 11a, or the elastic container 11b, to the gas distribution device 20; or can be segmented, so that part of it is connected to the rigid container 11a. or the elastic container 11b, and its other part is connected to the gas distribution device 20, and only during application to the patient's head are they connected to each other to form a continuous inlet tube 12a.
  • the amount of mixture of gases 15a stored in the container when released outside cap 13, is diluted by surrounding air such that the diluted mixture reaches non-toxic levels to the patient
  • the amount of mixture of gases 15a stored in the container is such that it would be highly toxic to the lice in a high concentration, and non-toxic to the patient if accidentally released into the surrounding air.
  • the high concentration is achieved by defining and sealing the space 16 around the patient's head 300 and delivering mixture of gases 15a only into space 16
  • the container holds mixture of gases 15a in a compressed state. Holding mixture of gases 15a in a compressed state allows a rapid release of mixture of gases 15a into airtight space 16
  • cap 13 is a version of a swim cap, worn tightly on the patient's head.
  • cap 15a is a version of a shower cap, worn loosely on the patient's head.
  • cap 13 is made in a version that is attractive in color and form to children
  • cap 13 is made of at least one of the following materials: silicone, rubber, polyethylene, latex, lycra, or cloth coated with a gas-tight layer.
  • exemplary composition of the gas mixture may include butane mixed with nitrogen, in a ratio ranging from 2:8 to 7:3 respectively. These gases are toxic.
  • the cap is configured to enable the mixture of gases to gradually flow outside of the cap to enhance safety.
  • exemplary duration of treatment ranges from 10 seconds to 30 minutes.
  • the cap 13 is configured to comprise small holes enabling a slow escape of the gas mixture, or alternatively the cap is made of a fabric made to allow slow gas escape of gas to the outside and air to the inside.
  • cap 13 is attached to the patient's head and sealed by sealing means 17 for preventing mixture of gases 13 from escaping out of cap 13.
  • sealing means 17 comprises of a rubber band on the rim of cap 13. Sealing cap 13 provides a higher effectiveness of applied mixture of gases 15a as well as enhanced user safety
  • mixture of gases 15a comprises a gas with low molecular weight and high diffusivity. These properties are needed to allow a quick penetration of the gas to airtight space 16, below hair 14 and into the tracheal system of the lice.
  • mixture of gases 15a comprises a gas having a molecular weight below 100 Dalton, for example gaseous hydrocarbons, NH 3 , SO 2 , CO 2 , CO.
  • mixture of gases 15a comprises a gas having a molecular weight below 1,000 Dalton, for example amino acids and peptides.
  • mixture of gases 15a depletes oxygen from airtight space 16 by physical or chemical means.
  • Such means may be inert gases like N 2 that displace oxygen with airtight space 16 and within the tracheae of the lice.
  • the oxygen depletion may be chemically achieved by a reaction between at least one of the gases in the mixture and the oxygen in the airtight space.
  • a unidirectional valve 18 is attached to cap 13.
  • the unidirectional valve is configured to allowing air out of cap 13 but preventing air from entering cap 13
  • the unidirectional valve 18 further reduces the airtight space 16 around the head of the patient, particularly depleting oxygen out of airtight space Using the unidirectional valve also enhances the affectivity of mixture of gases 15a by concentrating the fixed amount of mixture of gases 15a in container 11 to a smaller space 16.
  • mixture of gases 15a causes irreversible damage to at least one essential mechanism of the lice, such as the mitochondria, nervous system, reproductive system, feeding system, etc.
  • mixture of gases 15a comprises of specific inhibitors or destroyers of enzymes or reactions related to the proper functioning of these systems
  • mixture of gases 15a comprises of compounds preventing copulation or compounds that render nits sterile.
  • Figure 7a illustrates the first embodiment of a system 100a, for treating lice and nits, on a head 300 of a patient, according to the present invention, in which the active material is stored separately within an active material container 30.
  • the active material container 30 is connected on both ends to inlet tube 12a.
  • the rigid container 11a or elastic container 11b contains gas 15b at a sufficient pressure to maintain flow through the active material container 30 during use.
  • Figure 7b shows two active material containers 30, according to the present invention.
  • the right one contains a sponge 33 immersed with active material and the left one contains a coil 32 which contains an active material 15c.
  • Figure 8 is a block diagram schematically illustrating a method of treating lice and nits on a head of a patient, according to some embodiments of the invention
  • the method includes:

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
EP09163262A 2009-05-27 2009-06-19 Traitement anti-poux avec composés gazeux dans un espace hermétique Withdrawn EP2255778A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/473,058 US20090235949A1 (en) 2007-01-04 2009-05-27 Treating lice with gaseous compounds in an airtight space

Publications (1)

Publication Number Publication Date
EP2255778A1 true EP2255778A1 (fr) 2010-12-01

Family

ID=42702294

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09163262A Withdrawn EP2255778A1 (fr) 2009-05-27 2009-06-19 Traitement anti-poux avec composés gazeux dans un espace hermétique

Country Status (1)

Country Link
EP (1) EP2255778A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2438830A1 (fr) 2010-10-10 2012-04-11 Novomic Ltd. Traitement anti-poux avec composés gazeux dans un espace hermétique
US9307820B2 (en) 2007-01-04 2016-04-12 Novomic Ltd. Treating lice with gaseous compounds in an airtight space
WO2017119814A1 (fr) * 2016-01-08 2017-07-13 Tralala Holding B.V. Dispositif de traitement de la tête

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2033357A (en) 1933-06-03 1936-03-10 Lethelin Products Company Inc Apparatus and process for killing human and animal vermin
EP0221004A2 (fr) 1985-11-01 1987-05-06 Iosef Scolnik Méthode et dispositif pour enlever les poux et les lentes
EP0279523A2 (fr) * 1987-01-22 1988-08-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions pour la destruction des poux contenant des acides carboxyliques
EP0968706A2 (fr) * 1998-07-02 2000-01-05 Eli Lilly And Company Compositions contenant de l'spynosine pour controller les poux humains
WO2000057704A1 (fr) 1999-03-26 2000-10-05 Campina Melkunie B.V. Procede et composition de lutte contre les parasites
WO2007056813A1 (fr) 2005-11-18 2007-05-24 Wild Child Formule pédiculicide/ovicide
WO2007124446A2 (fr) * 2006-04-20 2007-11-01 Transdermal Cap, Inc. Appareil pour livraison d'agents au et par le cuir chevelu humain
US9913925B2 (en) 2014-11-14 2018-03-13 Attends Healthcare Products, Inc. Synthetic surfactant-free finish, sheet having synthetic surfactant-free finish, articles having sheet with synthetic surfactant-free finish, and related methods

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2033357A (en) 1933-06-03 1936-03-10 Lethelin Products Company Inc Apparatus and process for killing human and animal vermin
EP0221004A2 (fr) 1985-11-01 1987-05-06 Iosef Scolnik Méthode et dispositif pour enlever les poux et les lentes
EP0279523A2 (fr) * 1987-01-22 1988-08-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions pour la destruction des poux contenant des acides carboxyliques
EP0968706A2 (fr) * 1998-07-02 2000-01-05 Eli Lilly And Company Compositions contenant de l'spynosine pour controller les poux humains
WO2000001347A2 (fr) 1998-07-02 2000-01-13 Eli Lilly And Company Formulations anti-poux pour l'homme
WO2000057704A1 (fr) 1999-03-26 2000-10-05 Campina Melkunie B.V. Procede et composition de lutte contre les parasites
WO2007056813A1 (fr) 2005-11-18 2007-05-24 Wild Child Formule pédiculicide/ovicide
WO2007124446A2 (fr) * 2006-04-20 2007-11-01 Transdermal Cap, Inc. Appareil pour livraison d'agents au et par le cuir chevelu humain
US9913925B2 (en) 2014-11-14 2018-03-13 Attends Healthcare Products, Inc. Synthetic surfactant-free finish, sheet having synthetic surfactant-free finish, articles having sheet with synthetic surfactant-free finish, and related methods

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9307820B2 (en) 2007-01-04 2016-04-12 Novomic Ltd. Treating lice with gaseous compounds in an airtight space
EP2438830A1 (fr) 2010-10-10 2012-04-11 Novomic Ltd. Traitement anti-poux avec composés gazeux dans un espace hermétique
WO2017119814A1 (fr) * 2016-01-08 2017-07-13 Tralala Holding B.V. Dispositif de traitement de la tête

Similar Documents

Publication Publication Date Title
US20090235949A1 (en) Treating lice with gaseous compounds in an airtight space
EP2255778A1 (fr) Traitement anti-poux avec composés gazeux dans un espace hermétique
CN108353708B (zh) 一种西番莲茎基腐病的防治方法
US20120085363A1 (en) Treating lice with gaseous compounds in an airtight space
ES2749602T3 (es) Composición de dispersión líquida libre de siloxano que comprende isopropilmiristato e isohexadecano para combatir ectoparásitos
CN101491491B (zh) 长效驱蚊凝露
CN105918365A (zh) 植物精油在防治梭毒隐翅虫中的应用
US20160220801A1 (en) Treating lice with gaseous compounds in an airtight space
US20210315193A1 (en) Bio-robotic device for luring and killing hematophagous arthropods
EP0221004A2 (fr) Méthode et dispositif pour enlever les poux et les lentes
CN1209273A (zh) 一种无公害植物杀蚊蝇剂
CN110623002A (zh) 一种青蒿蜡油驱虫剂的制备方法
US6921545B2 (en) Synergistic control of pests
WO2014009881A1 (fr) Traitement de poux à l'aide de composants gazeux dans un espace étanche à l'air
DE19618210C2 (de) Verfahren und Einrichtung zum Bekämpfen von Schädlingen
CN108935388A (zh) 一种仿生灭蚊虫的方法及装置
CN106973901B (zh) 一种用于防治文物虫霉的熏蒸方法
CN114631530B (zh) 控制或防治昆虫的界面活性剂组成物及其使用方法
KR102918043B1 (ko) 계피오일을 이용한 친환경 연무 연막제
KR20250100231A (ko) 해충 기피제 조성물 및 이를 이용한 해충 기피 방법
RU119614U1 (ru) Устройство для выделения летучих компонентов активного вещества
CN109418247A (zh) 便捷胶囊型手持式灭虫器
JPH045202A (ja) 殺菌、殺虫剤及び殺菌、殺虫方法
CN106509002A (zh) 一种防治根结线虫的熏蒸剂及其制备方法
Pyenson et al. The toxic effects of naphthalene on Bruchus obtectus and Tenebrio molitor in various stages of development

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110602